a patient who clicks through without checking can land on a dodgy dispenser
second-generation long-acting analogues such as cagrilintide under late-stage clinical development, often combined with GLP-1 therapy for enhanced weight loss), (b) small molecules or peptides designed to inhibit amylin misfolding and aggregation to protect -cells, and (c) immunotherapeutic or vaccine approaches targeting pathological IAPP species
Participants received once-weekly subcutaneous injections of retatrutide at doses of 0.5 mg, 4 mg, 8 mg, or 12 mg, or placebo, over a 24-week treatment period, with gradual dose escalation to the target maintenance dose
The flu vaccination: who should have it and why (winter 2025 to 2026) Richards, R., et al
Unpredictable Allergic Reactions and Hives (MCAS): Oxidative stress acts as a direct trigger for mast cell degranulation
The researchers focused on a class of drugs called GLP-1 receptor agonists